NDAINJECTIONINJECTABLE
Approved
Aug 1939
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DOCA (desoxycorticosterone acetate) is a synthetic corticosteroid administered via injection, approved in 1939 as one of the earliest steroid therapeutics. It acts as a mineralocorticoid and glucocorticoid, historically used for adrenal insufficiency, shock, and electrolyte disorders. This legacy product remains a niche therapeutic option in specialized endocrine and critical care settings.
LOE Approaching
This legacy product is approaching loss of exclusivity with minimal commercial support infrastructure, suggesting a small, maintenance-focused team rather than growth-stage investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Started Jun 2026
100 enrolled
Chin Augmentation
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
Started Apr 2026
30 enrolled
Infective Endocarditis (IE)
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Started Feb 2026
20 enrolled
Leg Veins
Lidocaine for LESS Postoperative Shoulder Pain Alleviation
Started Dec 2025
100 enrolled
CystectomyMyomectomy
A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine
Started Jul 2025
171 enrolled
Skin Quality Improvement
Worked on DOCA at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.